The 12th IMPACCT Real World Evidence Summit is set to take place October 29–31 in Boston. Featured speaker Kelly H. Zou, who serves as head of global medical analytics, real world evidence, and health economics and outcomes research at Viatris, tells us a little about what participants can expect.
real-world evidence
Member Kelly Zou Dives into Real-World Evidence
IMPACCT: Real World Evidence Summit organizer Hanson Wade interviewed speaker Kelly Zou about the use of real-world evidence for regulatory submissions and improved clinical trial design.
Viatris Wins 2021 Global CPhI Pharma Award for Digital Innovation
The award recognizes a set of projects that harness real-world evidence and artificial intelligence for regulatory use over a three-year period.
Panel Provides Insights on Real-World Evidence in Health Care
Real-world data (RWD) can come from a variety of sources, including claims, electronic health records, biobanks, genomics tests, and imaging modalities. Increasingly, it is coming from digital data through electronic health and mobile health modalities. Recent events have pushed innovation in the use of RWD to maximize the value of real-world evidence in an era of big data, data science, and artificial intelligence.
NYU Abu Dhabi and Pfizer Inc. Collaboration Drives Progress
New York University Abu Dhabi and the Upjohn Division of Pfizer Inc. work to build scientific research capacity in the United Arab Emirates. The long-term vision of the partnership is to harness observational data, randomized clinical trials, and analytical skills to generate real-world evidence to advance the prevention and management of noncommunicable diseases.
Meet Sylva Collins, Director of the Office of Biostatistics, US Food and Drug Administration
Sylva Collins joined the FDA’s Office of Biostatistics in 2019 and has more than 30 years of drug development experience and biostatistics leadership.